Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Aktis Oncology, Inc. (AKTS) vs. Competitors

43 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AKTSAktis Oncology, Inc.$16.16$898.81M-10.42-27.86%Strong BuyUnlock the AKTS analyst price target with TipRanks PremiumAKTSUnlock the AKTS top-analyst price target with TipRanks Premium
IOVAIovance Biotherapeutics$7.55$3.49B-14.24205.67%Strong BuyUnlock the IOVA analyst price target with TipRanks PremiumAKTS vs IOVAUnlock the IOVA top-analyst price target with TipRanks Premium
ZYMEZymeworks$26.45$1.84B39.7542.82%Strong BuyUnlock the ZYME analyst price target with TipRanks PremiumAKTS vs ZYMEUnlock the ZYME top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.52$779.47M-5.68-38.61%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumAKTS vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
IMCRImmunocore Holdings$28.88$1.49B-45.95-19.67%Moderate BuyUnlock the IMCR analyst price target with TipRanks PremiumAKTS vs IMCRUnlock the IMCR top-analyst price target with TipRanks Premium
NBTXNanobiotix$28.54$1.47B-23.9337.21%Moderate BuyUnlock the NBTX analyst price target with TipRanks PremiumAKTS vs NBTXUnlock the NBTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%500%600%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AKTSAktis Oncology, Inc.16.16-6.24-27.86%
IOVAIovance Biotherapeutics7.555.13211.98%
ZYMEZymeworks26.452.5510.67%
ORICOric Pharmaceuticals7.52-4.54-37.65%
IMCRImmunocore Holdings28.88-7.69-21.03%
NBTXNanobiotix28.546.6530.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts